11β-HSD1-IN-9 is a potent 11β-HSD1 inhibitor with IC50 values of 0.48 µM and 1.3 µM against human and rodent 11β-HSD1, respectively; it exhibits competitive interaction with rat 11β-HSD1 and is used in research on obesity, hyperglycemia, and cognitive impairment.